ESPARMA GMBH has a total of 20 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are CONNETICS AUSTRALIA PTY LTD, COLUMBIA LAB INC and BAROODY LLOYD J.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 4 | |
#3 | United States | 4 | |
#4 | Germany | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Specific use of cosmetics | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Koegst Dieter | 20 |
#2 | Fries Gerhard | 20 |
#3 | Huschka Christoph | 13 |
#4 | Neubert Reinhard | 13 |
#5 | Wohlrab Wolfgang | 13 |
#6 | Ansorge Siegfried | 7 |
#7 | Mueller Peter-Juergen | 6 |
#8 | Ozegowski Joerg-Herman | 6 |
#9 | Taeger Michael | 6 |
#10 | Schneider Juergen | 4 |
Publication | Filing date | Title |
---|---|---|
DE10360954B3 | Use of silibinin, its salts and / or its prodrugs together with α-lipoic acid for the treatment of chronic obstructive pulmonary diseases | |
DE10125882A1 | Medicaments containing ambroxol, its salts and / or prodrugs together with α-lipoic acid in the context of the treatment of diabetes mellitus | |
AU2101800A | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis | |
WO0038732A1 | Hyaluronate lyase used for promoting penetration in topical agents | |
DE19908487A1 | Pharmaceutical preparation containing dithranol |